Morphic Holding, Inc.

NASDAQ:MORF

56.99 (USD) • At close August 15, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 00-60.236060.2360.5216.1352.05560.2362.3829.5563.1243.8483.2655.90125.7577.6935.594-0.3345.6755.5676.0683.358000
Cost of Revenue 0.2750.2820.280.2860.2680.2570.2430.25125.6520.2630.27620.96624.55218.61318.75315.99819.91818.9616.8212.63513.90710.377.2875.7675.2934.284
Gross Profit -0.275-0.282-60.516-0.28659.9680.2645.8921.80434.5842.1199.28-17.842-20.704-15.348-12.8529.759-12.225-13.366-17.154-6.96-8.34-4.302-3.929-5.767-5.293-4.284
Gross Profit Ratio 001.00500.9960.5070.960.8780.5740.890.971-5.711-5.38-4.701-2.1780.379-1.589-2.38951.359-1.226-1.498-0.709-1.17000
Reseach & Development Expenses 48.99642.15939.85234.36435.71930.44924.70225.24525.65226.46323.65820.96624.55218.61318.75315.99819.91818.9616.8212.63513.90710.377.2875.7675.2934.284
General & Administrative Expenses 15.96211.1639.57910.3849.5839.2778.0148.3038.2347.5917.4447.2767.1395.9535.1274.7514.1954.4233.4262.8982.0771.8322.0441.4050.9720.935
Selling & Marketing Expenses 00000000000000000000000000
SG&A 15.96211.1639.57910.3849.5839.2778.0148.3038.2347.5917.4447.2767.1395.9535.1274.7514.1954.4233.4262.8982.0771.8322.0441.4050.9720.935
Other Expenses 00-0.0070.00700.002-0.001-0.1560.0110.0010.0120-0.007-0.01200000-0.09400-0.028-0.0160-0.016
Operating Expenses 64.95853.32249.43144.74845.30239.72632.71633.54833.88634.05431.10228.24231.69124.56623.8820.74924.11323.38320.24615.53315.98412.2029.3317.1726.2655.219
Operating Income -65.233-53.604-49.431-44.748-45.302-39.205-26.581-31.49326.35-31.672-21.546-25.118-27.843-21.301-17.9795.008-16.42-17.789-20.58-9.858-10.417-6.134-5.973-7.172-6.265-5.219
Operating Income Ratio 000.8210-0.752-75.25-4.333-15.3250.437-13.296-2.255-8.04-7.236-6.524-3.0470.194-2.134-3.1861.617-1.737-1.871-1.011-1.779000
Total Other Income Expenses Net 7.8888.398.8238.6196.4273.1022.241.5010.4930.1880.1440.0770.0280.0170.0870.2310.4070.8861.0921.2981.1191.0630.6290.0950.0340.039
Income Before Tax -57.345-45.214-40.608-36.129-38.875-36.103-24.341-29.99226.843-31.484-21.402-25.041-27.815-21.284-17.8925.239-16.013-16.903-19.488-8.56-9.298-5.071-5.344-7.077-6.231-5.18
Income Before Tax Ratio 000.6740-0.645-69.296-3.968-14.5950.446-13.217-2.24-8.016-7.228-6.519-3.0320.203-2.082-3.02258.347-1.508-1.67-0.836-1.591000
Income Tax Expense 0.240.080.127-0.0830.1380.0320.0360.0290.002-0.1880.570-0.035-0.029-0.143-0.115-0.155-0.1570.3430.3040.1350.129-0.657-0.1110-0.055
Net Income -57.585-45.294-40.735-36.212-39.013-36.135-24.377-30.02126.841-31.296-21.402-25.041-27.815-21.284-17.7495.354-15.858-16.746-19.831-8.864-9.433-5.2-5.344-7.077-6.231-5.18
Net Income Ratio 000.6760-0.648-69.357-3.973-14.6090.446-13.139-2.24-8.016-7.228-6.519-3.0080.208-2.061-2.99459.374-1.562-1.694-0.857-1.591000
EPS -1.15-0.91-0.82-0.73-0.92-0.9-0.63-0.780.7-0.84-0.59-0.69-0.77-0.63-0.580.18-0.52-0.55-0.66-0.3-0.32-0.18-0.23-0.31-0.27-0.23
EPS Diluted -1.15-0.91-0.82-0.73-0.92-0.9-0.63-0.780.68-0.84-0.59-0.69-0.77-0.63-0.580.18-0.52-0.55-0.66-0.3-0.32-0.18-0.23-0.31-0.27-0.23
EBITDA -64.958-53.322-49.151-44.462-45.034-38.948-26.338-31.24226.598-31.409-21.27-24.872-27.59-21.046-17.7055.291-16.134-17.506-20.335-9.647-10.218-5.968-5.829-7.037-6.132-5.092
EBITDA Ratio 000.8160-0.752-75.25-4.293-15.2030.442-13.186-2.226-7.962-7.17-6.446-30.205-2.097-3.12960.883-1.7-1.871-0.984-1.736000